Clinical Trial Update: SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing inhaled fluticasone propionate/salmeterol combination to fluticasone propionate alone in adolescents and adults with asthma; completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2016-01-14